The Digital Apothecary

DECEMBER 30, 2019

Well, 2019 is drawing to a close, and I thought it would be good to give a recap to what I've worked on with The Digital Apothecary this year. Overall, I would say it's been one of my most successful years, with over 40,000 visitors - which as a blog that puts out only a few articles a week - I am quite happy about it. Surprisingly, I have found LinkedIn to be one of my most abundant sources of engagements this year, and I think I will start pushing more content on that side.

52

52

pharmaphorum

DECEMBER 3, 2019

Research from Ashfield Meetings & Events clearly demonstrates that face-to-face meetings and events form a major part of continuing medical education (CME). National and international congresses have been identified as the primary event to attend by HCPs. But what makes congresses such a valuable education channel for time-restricted physicians? This pharmaphorum webinar, in association with Ashfield Meetings & Events, will dive into a unique study of HCP educational and behavioural preferences

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Med Ed 101

DECEMBER 29, 2019

From the very beginning of Meded101 and Real Life Pharmacology, my goal has been to educate as many healthcare professionals as possible about medication safety. I’m continuing that theme with my latest project, and I want to give it away to you as cheap as Amazon will let me. My latest creation took about 6 […]. The post New Release! 200+ Page Drug Interaction Book for Virtually Nothing… appeared first on Med Ed 101.

40

40

Med Ed 101

DECEMBER 25, 2019

OTC Tamiflu may be a reality in the near future. Sanofi has purchased the over-the-counter rights for Tamiflu and is pursuing approval from the FDA. I do have some potential concerns with this medication becoming an over-the-counter option. For the pharmacology, adverse effects, drug interactions, and more on Tamiflu (oseltamivir), take a listen to this […].

FDA 40

FDA 40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

DECEMBER 22, 2019

I’ve worked within the walls of numerous types of settings that have access to life-saving and life-threatening medications. Whether it be at a clinic, long term care facility, assisted living facility, or hospital, it can be easy for staff to have a cavalier attitude about the access to medications. I read this VA article and […]. The post Fatal Insulin Injections and Security of Medications appeared first on Med Ed 101.

Long-Term Care Facilities 40

Long-Term Care Facilities Assisted Living Hospitals 40

Med Ed 101

DECEMBER 18, 2019

As I look ahead to help all of you prepare for the 2020 BCPS exam changes, I want to make sure that everyone is on the same page in how this might affect your studying. Questions about the exam? You MUST check out this post on FAQ’s and more. 2020 BCPS Exam Changes – Timing […]. The post 2020 BCPS Exam Changes – How to Prepare appeared first on Med Ed 101.

40

40

Med Ed 101

DECEMBER 11, 2019

Both salmeterol and formoterol are considered long-acting beta-agonists. These agents have been commonly used in the setting of asthma and COPD. Each of these agents is most commonly combined with an inhaled corticosteroid. Budesonide is coupled with formoterol in the brand name product Symbicort. Salmeterol is most commonly coupled with fluticasone in the brand name […].

40

40

Med Ed 101

DECEMBER 8, 2019

With the recent changes in the Beers Criteria, glimepiride has now been added to the list of sulfonylureas to avoid. Glipizide is the preferred agent if a sulfonylurea is to be used. This begs the question, should we recommend changing glimepiride to glipizide? In my opinion, this is definitely a gray area and an argument […]. The post Changing Glimepiride to Glipizide…to Rock the Boat or Not?

40

40

Med Ed 101

DECEMBER 4, 2019

A 72-year-old male has a past history of heart failure with reduced ejection fraction, chronic kidney disease, hypertension, diabetes, intermittent claudication, and osteoarthritis. His current medication regimen includes: Aspirin 81 mg daily Cilostazol 100 mg twice daily Furosemide 40 mg twice daily Amlodipine 10 mg daily Lisinopril 10 mg daily Carvedilol 6.25 mg twice daily […].

40

40

Med Ed 101

DECEMBER 1, 2019

In keeping it real today, I wanted to share my top 5 medications that worsen dementia. This list is totally anecdotal based upon my experience and the frequency with which I see these medications used in clinical practice. Without further ado, here are my top 5 medications that worsen dementia! Medications That Worsen Dementia – […]. The post Top 5 Medications That Worsen Dementia appeared first on Med Ed 101.

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA